Applied DNA Sciences (APDN)
(Delayed Data from NSDQ)
$5.00 USD
+4.76 (1,993.80%)
Updated Apr 25, 2024 03:59 PM ET
After-Market: $5.00 0.00 (0.00%) 4:46 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Applied DNA Sciences Inc [APDN]
Reports for Purchase
Showing records 81 - 100 ( 165 total )
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
FY2Q21: Strong Revenue Growth, Positive COVID-19 Test Developments
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Receives NY State CLIA Certification, Allowing Greater Revenue Capture
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Veterinary COVID-19 Vaccine Increases Antibody Titers Enough to Proceed
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
U.S. Defense Logistics Agency Contract Shows Appeal of Authentication
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Preliminary F2Q21 Results Reported; Reiterate Buy; Lowering PT to $13
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Preannounces Above Consensus $2.5-2.7M FY2Q21 Revenue, ADCL
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
SARS-CoV-2 Mutation Tracking Program With Northwell Health; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Establishes SARS-CoV-2 Mutation Tracking Program with Northwell Health
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Healthcare -COVID-19 Therapeutics Panel Takeaways
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Variant Detecting COVID-19 Diagnostic Tests Should Drive FY2021 Revenue
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Launches COVID Surveillance Mutation Panel to Increase Variant Detection
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Proof of Principle Feline Veterinary COVID-19 Vaccine Trial Initiated
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J